Velpatasvir is an antiviral medication used in combination with sofosbuvir (commonly known as Epclusa) to treat chronic Hepatitis C (HCV) infection across all six genotypes. Taken orally once daily, this 12-week regimen, which works by inhibiting the NS5A protein to stop virus replication, achieves over 95% cure rates
See It Styled On Instagram
- No access token
Reviews
There are no reviews yet.